上QQ阅读APP看书，第一时间看更新
参考文献
1. Parker HE，Habib AM，Rogers GJ. et al. Nutrient-dependent secretion of glucose—dependent insulinotropic polypeptide from primary murine K cells.Diabetologia，2009，52：289-298.
2. Reimann F. Molecular mechanisms underlying nutrient detection by incretin-secreting cells. Int Dairy J，2010，20：236-242.
3. Cho YM，Kieffer TJ.K-cells and glucose-dependent insulinotropicpolypeptide in health and disease.Vitam Horm，2010，84：111-150.
4. Mayo KE，Miller LJ，Bataille D，et al. International Union of Pharmacology.XXXV.The glucagon receptor family. Pharmacol Rev，2003，55（1）：167-194.
5. Parker HE，Habib AM，Rogers GJ. et al. Nutrient-dependent secretion of glucose—dependent insulinotropic polypeptide from primary murine K cells.Diabetologia 2009，52：289-298.
6. Reimann F. Molecular mechanisms underlying nutrient detection by incretin-secreting cells. Int Dairy J，2010，20：236-242.
7. Song DH，Getty-Kaushik L，Tseng E，et al.Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Gastroenterology，2007，133（6）：1796-1805.
8. Weaver RE，Donnelly D，Wabitsch M，et al.Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.Int J Obes（knd），2008，32（11）：1705-1711.
9. Getty-Kaushik L，Song DH，Boylan MO，et al.Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification.Obesity（Silver Spring），2006，14（7）：1124-1131.
10. Miyawaki K，Yamada Y，Ban N，et al.Inhibition of gastric inhibitory polypeptide signaling prevent obesity.Nat Med，2002，8（7）：738-742.
11. Kim SJ，Nian C，McIntosh CH.Resistin is a key mediator of glucose-dependent insulinotropic polypeptide（GIP）stimulation of lipoprotein lipase（LPL）activity in adipocytes.J Biol Chem，2007，282（47）：34139-34147.
12. Yip RG，Wolfe MM. GIP biology and fat metabolism. Life Sci 2000，66（2）：91-103.
13. Holz G G，Leech C A，Heller R S，et al. cAMP-dependent mobilization of intracellular Ca 2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca 2+ signaling system stimulated by the insulinotropic hormone glucagon- like peptide-1-（7-37）. J Biol Chem，1999，274（20）：14147～14156.
14. Bode H P，Moormann B，Dabew R，et al. Glucagon-like peptide1elevates cytosolic calcium in pancreatic b-cells independently of protein kinase A. Endocrinology，1999，140（9）：3919～3927.
15. Gu W.Nie AH.Li S.Research development on DPP.Ⅳ's targeting T2DM drugs.Chin J Med Chem（中国药物化学杂志），2004，14（6）：373-378.
16. WEBER A E.Dipeptidyl peptidase Ⅳ inhibitors for the treatment of diabetes.JMed Chem，2004，47（17）：41354-141.
17. Xiao Q，Giguere J，Parisien M，et al.Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo.Biochemistry，2001，40（9）：2860-2869.
18. Neumiller JJ，Wood L，Campbell RK.et al.Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Pharmacotherapy，2010，30（5）：463-484.
19. Kar NC，Pearson CM. Dipeptidyl peptidases in human muscle disease. Clin Chim Acta，1978，82（1-2）：185-192.
20. Wani AA，Devkar N，Patole MS，et al. Description of two new cathepsin C gene mutations in patients with Papillon-Lefèvre syndrome. J Periodontol，2006，77 （2）：233-237.
21. Meade JL，de Wynter EA，Brett P，et al. A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity. Blood 2006，107 （9）：3665-3668.
22. Turk D，Janjic V，Stern I，et al. Structure of human dipeptidyl peptidase Ⅰ （cathepsin C）：Exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. The EMBO Journal，2001，20 （23）：6570-6582.
23. Maes MB，Scharpe S，De Meester I. Dipeptidyl peptidase Ⅱ （DPPⅡ），a review. Clin Chim Acta，2007，380（1）：31-49.
24. Inomata M，Nomura K，Takehana M，et al. Evidence for the involvement of calpain in cataractogenesis in Shumiya cataract rat （SCR）. Biochim Biophys Acta，1997，1362：11-23.
25. Araki H，Li Y，Yamamoto Y，et al. Purification，Molecular Cloning，and Immunohistochemical Localization of Dipeptidyl Peptidase Ⅱ from the Rat Kidney and Its Identity with Quiescent Cell Proline Dipeptidase. J Biochem，2001，129，279-288.
26. Leiting B，Pryor KD，Wu JK，et al. Catalytic properties and inhibition of proline-specific dipeptidyl peptidases Ⅱ，Ⅳ and Ⅶ. Biochem J，2003，371，525-532.
27. Rosenstock J，Zinman B. Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes，2007，14 （2）：98-107.
28. Pro B，Dang N. CD26/dipeptidyl peptidase Ⅳ and its role in cancer. Histol Histopathol，2004，19 （4）：1345-1351.
29. Masur K et al. “DPPⅣ inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells”. Regul Pept，2006，137 （3）：147-55.
30. Wesley UV，McGroarty M，Homoyouni A. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res，2005，65 （4）：1325-1334.
31. Havre PA，Abe M，Urasaki Y，et al. The role of CD26/dipeptidyl peptidase Ⅳ in cancer. Front. Biosci，2008，13 （13）：1634-1645.
32. Raj VS，Mou H，Smits SL，et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature，2013，495 （7440）：251-254.
33. Deng J，Lamb JR，McKeown AP，et al. Identification of altered dipeptidyl-peptidase activities as potential biomarkers for unipolar depression. J Affect Disord，2013，151（2）：667-672.
34. Fukasawa K，Fukasawa KM，Kanai M，et al. Dipeptidyl peptidase Ⅲ is a zinc metalloexopeptidase. Molecular cloning and expression. Biochem J，1998，329（Pt 2）：275-282.
35. Simaga S，Abramic M，Osmak M，et al. Total tissue lactate dehydrogenase activity in endometrial carcinoma. Int J Gynecol Cancer，2008，18（6）：1272-1278.
36. Simaga S，Babic D，Osmak M，et al. Tumor cytosol dipeptidyl peptidase Ⅲ activity is increased with histological aggressiveness of ovarian primary carcinomas. Gynecol Oncol，2003，91（1）：194-200.
37. Nadal MS，Ozaita A，Amarillo Y，et al. The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K + channels. Neuron，2003，37 （3）：449-461.
38. Zagha E，Ozaita A，Chang SY，et al. DPP10 modulates Kv4-mediated A-type potassium channels. J Biol Chem，2005，280 （19）：18853-18861.
39. Allen M，Heinzmann A，Noguchi E，et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet，2003，35 （3）：258-263.
40. Abbott CA，Yu DM，Woollatt E，et al. Cloning，expression and chromosomal localization of a novel human dipeptidyl peptidase （DPP） Ⅳ homolog，DPP8. Eur J Biochem，2000，267（20）：6140-6150.
41. Ajami K，Abbott CA，McCaughan GW，et al. Dipeptidyl peptidase 9 has two forms，a broad tissue distribution，cytoplasmic localization and DPIV-like peptidase activity. Biochim Biophys Acta，2004，1679 （1）：18-28.
42. Mentlein R，Gallwitz B，Schmidt WE. Dipeptidyl-peptidase Ⅳ hydrolyses gastric inhibitory polypeptide，glucagon-like peptide-1（7-36）amide，peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem，1993，214（3）：829-835.